The model can be accessed through Latent's web-based platform for push-button protein design. Sign ups are open now for early access: platform.latentlabs.com Extensive lab validation shows picomolar ...
BOSTON--(BUSINESS WIRE)--Manifold Bio, a platform therapeutics company pioneering direct-to-vivo drug discovery, today announced a joint study with NVIDIA to validate Proteina-Complexa, NVIDIA's ...
A vision of the future of protein engineering The new approach allows the identification of near-optimal binder templates from the human proteome, facilitating the humanization of designed therapies, ...
University of Virginia School of Medicine scientists have developed a bold new approach to drug development and discovery that could dramatically accelerate the creation of new medicines. UVA's ...
For the field of drug development, hitting the right target with atomic precision to achieve therapeutic effect remains the core challenge. While traditional R&D pipelines are dependent on ...
Google DeepMind has built SynthID Bio, a watermark for AI-designed proteins, and shown in wet-lab tests on protein binders that it leaves their function intact. The method hides a signature in the ...
The same week that Generate Biomedicines and Zealand Pharma announced a deal worth up to $1.2 billion to develop AI-designed protein therapeutics for obesity and metabolic disease, a University of ...
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. Latent-X generates lab-ready macrocycles and protein ...